Search Results 1001-1010 of 2004 for 搜索引擎平台开发咨询邮箱：lgooxc@hotmail.com
PRM-151 is an investigational drug that is being developed for possible use in the treatment of myelofibrosis (MF), a disease in which the bone marrow, which is ...
Fortune Ngufor, Emma Ph.D. fortune.emma@mayo.edu; Associate Professor of Biomedical Engineering; Assistant Professor of Health Care Systems Engineering ...
Mayo Clinic Center for Clinical and Translational Science (CCaTS) Office of Translation to Practice project management teams assist in product development.
The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose combination for subcutaneous ...
Also, many of you have inquired as to how you can donate so we can continue to help the girls of the Congo. You can mail checks to the Mayo Clinic Department of ...
About this study. The purpose of this study determine if treatment with sequential high dose testosterone and enzalutamide (STE) administered according to ...
This trial will look at a drug called SGN-TGT (an anti-TIGIT antibody) to find out whether it is safe for patients with solid tumors and lymphomas. It will ...
HLC accreditation allows Mayo Clinic College of Medicine and Science to access federal financial aid and to award degrees and certificates in the following: ...
About this study. The purpose of the study is collect specimens for future studies to identify markers circulating in the blood that are associated with the ...
Muscle insulin resistance is a hallmark of upper body obesity (UBO) and Type 2 diabetes (T2DM). It is unknown whether muscle free fatty acid (FFA) availability ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.